Difference between revisions of "PITUITARY-TUMORS"
(Imported from text file) |
(Imported from text file) |
||
| Line 6: | Line 6: | ||
<br/>2. Gonadotrophs (LH & FSH): common macroadenomas, present(s) with mass effect +/- hormonally silent / hyposecretion / hypersecretion | <br/>2. Gonadotrophs (LH & FSH): common macroadenomas, present(s) with mass effect +/- hormonally silent / hyposecretion / hypersecretion | ||
<br/> | <br/> | ||
<br/>3. Corticotrophs (ACTH) | <br/>3. Corticotrophs (ACTH): Cushing's disease | ||
<br/> | <br/> | ||
<br/>4. Somatotrophs (GH) | <br/>4. Somatotrophs (GH): acromegaly | ||
<br/> | <br/> | ||
<br/>5. Thyrotrophs (TRH) | <br/>5. Thyrotrophs (TRH): hyperthyroidism (uncommon) | ||
<br/> | <br/> | ||
<br/>6. Mixed cell types (PRL & GH) | <br/>6. Mixed cell types (PRL & GH): hyperprolactinemia & acromegaly | ||
Latest revision as of 02:29, 21 March 2023
SUMMARY
Abnormal proliferation of cells from anterior pituitary:
1. Lactotrophs (PRL): most common macroadenomas
2. Gonadotrophs (LH & FSH): common macroadenomas, present(s) with mass effect +/- hormonally silent / hyposecretion / hypersecretion
3. Corticotrophs (ACTH): Cushing's disease
4. Somatotrophs (GH): acromegaly
5. Thyrotrophs (TRH): hyperthyroidism (uncommon)
6. Mixed cell types (PRL & GH): hyperprolactinemia & acromegaly
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
